Walleye Trading’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Walleye Trading’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50,000	Closed	-$504K	–	5652
2022 Q4	$504K	Hold	50,000	–	–	﹤0.01%	2810
2022 Q3	$496K	Hold	50,000	–	–	﹤0.01%	2909
2022 Q2	$488K	Hold	50,000	–	–	﹤0.01%	2935
2022 Q1	$493K	Hold	50,000	–	–	﹤0.01%	2932
2021 Q4	$496K	Hold	50,000	–	–	﹤0.01%	2973
2021 Q3	$497K	Hold	50,000	–	–	﹤0.01%	2925
2021 Q2	$500K	Hold	50,000	–	–	﹤0.01%	2913
2021 Q1	$503K	Buy	+50,000	New	+$500K	﹤0.01%	2646

Walleye Trading's EBACU Position: Q1 2023 in Review

Walleye Trading sold out of European Biotech Acquisition Corp. Units (EBACU) in Q1 2023, closing a stake of 50,000 shares — an estimated $504K sold.

Walleye Trading first reported a position in EBACU in Q1 2021 and held it in 8 quarters. The position peaked at $504K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACU as of Q1 2023.

Walleye Trading reported no remaining European Biotech Acquisition Corp. Units position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 50,000 European Biotech Acquisition Corp. Units shares in Q1 2023, an estimated $504K.
Walleye Trading first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 8 quarters.
Walleye Trading's European Biotech Acquisition Corp. Units position peaked at $504K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.